On October 2, the Social Security Committee of the Chamber of Deputies passed a bill granting tax benefits for medicines used in the treatment of rare diseases, also known as “orphan drugs”. These include drugs used to combat hemophilia. The initiative now goes to the Committees of Finance, and Constitution and Justice, before discussion at plenary level.
The bill, introduced by Deputy Rejane Dias (Partido dos Trabalhadores – opposition), exempts income arising from the sale and import of this medication from paying contributions to the Social Integration Programme (PIS, for its acronym in Portuguese) and the Social Security Financing scheme (Cofins, for its acronym in Portuguese). The bill also grants credit to those companies manufacturing or importing these drugs and simplifies the process for their sanitary registration.
Regarding the bill, Alexandre Padilha (Partido dos Trabalhadores – opposition), said that “the reduction of the tax burden could lead to a reduction in the final price and thus facilitate access.” He also added that the benefits of such a reduction could “affect not only patients, but also wholesale medicine purchasers” since “products could be bought at lower prices.”